Circulation Research, Vol 74, 930-936, Copyright © 1994 by American Heart Association

ARTICLES

Distinct receptors and signaling pathways in alpha-thrombin- and thrombin receptor peptide-induced vascular contractions

B Tesfamariam
Department of Pharmacology, Bristol-Myers Squibb Research Institute, Princeton, NJ 08543.

The vasoactive mechanisms of the serine protease alpha-thrombin were examined in isolated coronary arteries from dogs. In resting coronary arteries with endothelium, alpha-thrombin caused concentration- dependent contractions that were characterized by an initial transient relaxation followed by slowly developing sustained contractions. The vascular actions of alpha-thrombin were mimicked by the thrombin receptor-activating peptide (TRAP) SFLLRNP, a synthetic peptide based on the cleaved terminus of the thrombin receptor domain. Treatment of the arteries with N omega-nitro-L-arginine or removal of endothelium abolished the transient relaxations and enhanced the contractions, indicating that the transient relaxations were mediated by the concurrent release of endothelium-derived nitric oxide. alpha-Thrombin that had been catalytically inactivated with the irreversible inhibitor by use of D-Phe-Pro-Arg-chloromethyl ketone did not cause contractions, indicating the requirement of proteolytic cleavage by alpha-thrombin to induce contractions. In contrast to TRAP, alpha-thrombin-induced contractions were blocked by hirudin (a specific thrombin inhibitor), nifedipine and diltiazem (Ca2+ channel blockers), or staurosporine and calphostin C (protein kinase C inhibitors). Unlike alpha-thrombin, which undergoes homologous desensitization, TRAP failed to cause desensitization to subsequent stimulation by alpha-thrombin or TRAP. These observations support the hypothesis that vasoactive actions of alpha-thrombin are mediated by a mechanism that involves cleavage at the active site to expose a new NH2 terminus that activates the thrombin receptor. Further, the dissociation between alpha-thrombin and the synthetic receptor peptide in signal transduction and dissimilar desensitizing properties suggest the existence of distinct thrombin receptor subtypes and/or signaling events in vascular smooth muscle.

This article has been cited by other articles:

				K. Hirano The Roles of Proteinase-Activated Receptors in the Vascular Physiology and Pathophysiology Arterioscler Thromb Vasc Biol, January 1, 2007; 27(1): 27 - 36. [Abstract] [Full Text] [PDF]

				Y. Gui, R. Loutzenhiser, and M. D. Hollenberg Bidirectional regulation of renal hemodynamics by activation of PAR1 and PAR2 in isolated perfused rat kidney Am J Physiol Renal Physiol, July 1, 2003; 285(1): F95 - F104. [Abstract] [Full Text] [PDF]

				J. J. Bosnjak, K. Terata, H. Miura, A. Sato, A. C. Nicolosi, M. McDonald, S. A. Manthei, T. Saito, O. A. Hatoum, and D. D. Gutterman Mechanism of thrombin-induced vasodilation in human coronary arterioles Am J Physiol Heart Circ Physiol, April 1, 2003; 284(4): H1080 - H1086. [Abstract] [Full Text] [PDF]

				S. R. Macfarlane, M. J. Seatter, T. Kanke, G. D. Hunter, and R. Plevin Proteinase-Activated Receptors Pharmacol. Rev., June 1, 2001; 53(2): 245 - 282. [Abstract] [Full Text] [PDF]

				J. R. Hamilton, P. B. Nguyen, and T. M. Cocks Atypical Protease-Activated Receptor Mediates Endothelium-Dependent Relaxation of Human Coronary Arteries Circ. Res., June 29, 1998; 82(12): 1306 - 1311. [Abstract] [Full Text] [PDF]

				M. I. Furman, L. Liu, S. E. Benoit, R. C. Becker, M. R. Barnard, and A. D. Michelson The cleaved peptide of the thrombin receptor is a strong platelet agonist PNAS, March 17, 1998; 95(6): 3082 - 3087. [Abstract] [Full Text] [PDF]

				Z. Yang, F. Ruschitzka, T. J. Rabelink, G. Noll, F. Julmy, H. Joch, V. Gafner, I. Aleksic, U. Althaus, and T. F. Luscher Different Effects of Thrombin Receptor Activation on Endothelium and Smooth Muscle Cells of Human Coronary Bypass Vessels : Implications for Venous Bypass Graft Failure Circulation, April 1, 1997; 95(7): 1870 - 1876. [Abstract] [Full Text]

				BrianD. Blackhart, K. Emilsson, D. Nguyen, W. Teng, ArnoldJ. Martelli, S. Nystedt, J. Sundelin, and RobertM. Scarborough Ligand Cross-reactivity within the Protease-activated Receptor Family J. Biol. Chem., July 12, 1996; 271(28): 16466 - 16471. [Abstract] [Full Text] [PDF]

				M. Eto, C. Barandier, L. Rathgeb, T. Kozai, H. Joch, Z. Yang, and T. F. Luscher Thrombin Suppresses Endothelial Nitric Oxide Synthase and Upregulates Endothelin-Converting Enzyme-1 Expression by Distinct Pathways: Role of Rho/ROCK and Mitogen-Activated Protein Kinase Circ. Res., September 28, 2001; 89(7): 583 - 590. [Abstract] [Full Text] [PDF]